Skip to main content

Table 2 Univariate and multivariate analysis of clinicopathologic variables associated with overall survival in 61 patients who underwent resection for primary retroperitoneal sarcoma

From: Analysis of outcomes and predictors of long-term survival following resection for retroperitoneal sarcoma

Variable

N (%)

5-year Overall Survival (%)

Univariate Analysis

P

Multivariate Analysis*

P

Hazard Ratio (95% CI)

Sex

  

.572

  

Male

29 (48)

45

   

Female

32 (52)

65

   

BMI (Body Mass Index)

  

.483

  

 < 25

28 (46)

65

   

 ≥25

33 (54)

52

   

Patient age at resection

  

.157

  

 ≥ 60 years

21 (35)

40

   

 18–59 years

38 (62)

68

   

 <  18 years

2 (3)

100

   

Tobacco use

  

.522

  

 Yes

15 (25)

44

   

 No

46 (75)

60

   

Tumour entity

  

.018

NS

 

 Leiomyosarcoma

19 (31)

71

   

 Liposarcoma, dedifferentiated

14 (23)

32

   

 Liposarcoma, well-differentiated

12 (20)

79

   

 Undifferentiated sarcoma, NOS

8 (13)

31

   

 Liposarcoma, pleomorphic

3 (5)

39

   

 Malignant Peripheral Nerve Sheath Tumours

3 (5)

33

   

 Other

3 (5)

78

   

Histologic grade, n (%)

  

.015

.030

2.26 (1.08–4.58)

 Low grade (G1)

21 (34)

92

   

 Intermediate grade (G2)

11 (18)

54

   

 High grade (G3)

29 (48)

43

   

AJCC 8th Ed., n (%)

  

.511

  

 Stage IA

2 (3)

94

   

 Stage IB

17 (28)

88

   

 Stage II

4 (7)

68

   

 Stage IIIA

8 (13)

59

   

 Stage IIIB

25 (41)

42

   

 Stage IV

5 (8)

19

   

Chemotherapy n (%)

  

.423

  

 None

49 (80)

61

   

 Neoadjuvant

2 (3)

51

   

 Adjuvant

10 (16)

41

   

Radiotherapy

  

.598

  

 None

44 (72)

58

   

 Neoadjuvant

4 (7)

67

   

 Adjuvant

13 (21)

70

   

Surgical resection margin

  

.186

  

 R0

33 (54)

61

   

 R1

18 (30)

45

   

 R2

2 (3)

0

   

 RX / Not stated

8 (13)

48

   

Vascular involvement

  

.333

  

 Yes

17 (28)

36

   

 No

44 (72)

62

   

ASA physical status

  

.066

  

 I

12 (20)

90

   

 II

32 (52)

63

   

 III

14 (23)

56

   

 IV

3 (5)

42

   

Need for intraoperative transfusions, %

  

.303

  

 No RBCC

32 (52)

56

   

 1–2 RBCC

13 (21)

59

   

 ≥ 3 RBCC

16 (26)

30

   
  1. * Cox regression multivariate analysis included all variables with P < 0.05 in univariate analysis. CI Confidence interval, NS Not significant, BMI Body-mass-index, ASA American Society of Anesthesiologists, AJCC American Joint Committee on Cancer Staging Manual, NOS Not otherwise specified, RBCC Red blood cell concentrate
  2. Entries with a p-value of < 0.05 in univariate or multivariate analysis are in boldface. A P value below 0.05 was considered significant.